Durable complete response to PET-CT driven stereotactic radiation therapy plus pembrolizumab for pleomorphic Pancoast cancer: Case report and literature review
CLINICAL CASE REPORTS(2024)
摘要
PET-driven SBRT plus pembrolizumab as first-line therapy against pleomorphic Pancoast cancer appears beneficial, probably due to high equivalent doses of SBRT on photopenic necrotic core and synergic immune system stimulation of immunoradiotherapy.
更多查看译文
关键词
image-guided radiation therapy,immune checkpoint inhibitors,Pancoast tumor,pleomorphic lung cancer,radioimmunotherapy,stereotactic body radiotherapy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要